RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.

Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Simão AL, Gaspar MM, Majdi A, Arretxe E, Alonso C, Santos A, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Banales J, Ratziu V, Gautheron J, Castro RE, Rodrigues CM. Gut. 2020 Dec 24:gutjnl-2020-321767. doi: 10.1136/gutjnl-2020-321767.